Has anyone considered leveraging publicly traded companies for deal sourcing? I am looking at a couple right now, have signed NDAs and exploring - however, the conversations I have had to date with external advisors - show that the transaction expenses will be much more significant than traditional deal constructs (e.g., P2P transactions). Obviously this impact returns - as the deal expenses representing ~10% of equity will create a higher threshold to enter the incentive fee. Thanks in advance!
ER
Sourcing: Pink Sheet and OTC Companies
by a searcher from Harvard University - Harvard Business School
More on Searchfunder
Searchfunder is an online community and toolkit for searchfunds. Over 80% of those involved in searchfunds maintain a Searchfunder.com account to help them network, problem solve challenges, and keep up with the industry.
We maintain partnerships with database providers that make searching more effective, efficient and affordable along with features that help searchers find deals and investors and vice versa.
We maintain partnerships with database providers that make searching more effective, efficient and affordable along with features that help searchers find deals and investors and vice versa.
I would expect the greatest difference between pink sheets and privately owned businesses are the paperwork and the middlemen.